The National Institutes of Health is putting more than $95 million into research tools designed to study human biology without relying as heavily on animals.
The new investment, announced September 21, includes $88 million for research facilities across the United States and more than $7 million in prizes for technologies that could improve drug safety and toxicity testing.
NIH is also building a laboratory that will combine human organoids, robotics and artificial intelligence to run experiments on human biological models.
The agency is not ending animal research. Its stated goal is to reduce animal testing where human-based methods can provide useful or more directly relevant data.
Where the $95 Million Is Going?
The largest part of the funding is $88 million for 10 construction projects under the NIH Biomedical Research Facilities Program.
According to the NIH announcement, the facilities will support research into areas including cancer, chronic disease, rare childhood diseases, environmental health, obesity and metabolic disorders.
Historically, some infrastructure funding supported facilities built around animal models. The new projects will put more emphasis on what researchers call New Approach Methodologies, or NAMs.
Those methods can include human cells and tissues, organoids, organs-on-chips and computer models.
A separate NIH challenge will offer more than $7 million for technologies that improve how researchers measure biological signals in these systems. One goal is to make laboratory models better at predicting whether a drug will be safe or toxic in people.
NIH Is Building a Lab Around Human Organoids and AI
NIH also plans to establish the Bio Genesis Autonomous Human Biology Laboratory at its Clinical Center.
The lab will use standardized human organoids together with robotics, AI and advanced data systems.
Organoids are small laboratory-grown structures made from human cells. They can reproduce some features of organs and tissues, allowing researchers to study disease and drug responses in human biological material without immediately moving to an animal experiment.
The NIH plan goes further than simply growing organoids in a dish. Automated systems will run experiments, collect results and use those results to help determine what the next experiment should test.
The aim is to create a repeatable system where researchers can study human biology faster and with more consistent models.
Why NIH Wants More Human-Based Research
Animal studies remain an important part of biomedical research, but results in animals do not always translate directly to humans.
A drug can work in mice and later fail in people. Diseases can also behave differently across species because of differences in physiology, metabolism, lifespan and immune responses.
That does not make animal testing and research useless. It means researchers need additional methods that can answer questions specifically about human biology.
The difference is important whenever animal studies make headlines. For example, research on rats we recently covered found lasting brain and behavioral changes in rats exposed to a synthetic psychedelic during adolescence, but the findings did not establish that the same effect occurs in human teenagers.
Human cell models and computational tools could help researchers test some of those questions earlier in the research process.
This Is Part of a Much Larger NIH Shift
The latest $95 million-plus investment is not an isolated program.
In March, NIH announced $150 million for human-based research methods under its Complement-ARIE program. Those projects are developing and standardizing laboratory and computer models intended to better represent human disease.
NIH then created the Office of Research Innovation, Validation, and Application in June. The office was established specifically to coordinate human-based research methods across the agency and help move validated techniques into wider use.
NIH has also said future funding opportunities will no longer be designed exclusively around animal models of human disease. Researchers can still use animals when scientifically justified, but funding opportunities are expected to leave more room for human-based approaches.
NIH Also Wants Better Numbers on Animal Testing
Another part of the September announcement deals with something much simpler: counting animals.
NIH is asking research institutions for feedback on whether they could report the number of live vertebrate animals used in NIH-funded research each year.
The agency says an annual report could make animal use more transparent and provide a way to measure whether its effort to reduce reliance on animals is actually working.
NIH is also recruiting more grant reviewers with experience in human-based research. That matters because new research proposals still need experts capable of judging whether organoids, computational models and other newer methods are scientifically appropriate.
Animal Research Is Not Disappearing
NIH has been careful not to describe the policy as a complete replacement for animal studies.
Some research questions still cannot be answered adequately with organoids, computer simulations or isolated human tissues. A laboratory model cannot yet reproduce every interaction that occurs across an entire living body.
NIH says animal models will continue to receive support when they are scientifically appropriate and properly justified.
The change is that researchers will have a larger set of alternatives and more federal money to develop them.
If those models become reliable enough to predict human responses earlier, they could reduce the number of animal experiments and help researchers identify failed drugs before they reach expensive clinical trials.
For now, the $95 million investment is less about ending animal research than building credible alternatives to it.
